| abstract |
The invention provides antibodies, functional fragments, modified and variant forms, antibody targets, nucleic acid and other compositions pertaining to TATA-binding protein-associated factor 15 (TAF 15). These antibodies functional fragments, modified and variant forms, nucleic acid and other compositions are useful in treatment, diagnostic and vaccination methods. One treatment method includes inhibiting growth or proliferation of proliferating cells, such as hyperproliferative cells or inducing regression of hyperprolif erative cells, such as cells of a cellular hyperproliferative disorder. |